Nanobiotix (NBTX) Revenue & Revenue Breakdown
Nanobiotix Revenue Highlights
Latest Revenue (Y)
$30.06M
Latest Revenue (Q)
$30.06M
Main Segment (Y)
Services
Main Geography (Y)
Other Sales
Nanobiotix Revenue by Period
Nanobiotix Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $30.06M | 529.36% |
| 2022-12-31 | $4.78M | 47660.00% |
| 2021-12-31 | $10.00K | -80.00% |
| 2020-12-31 | $50.00K | -26.47% |
| 2019-12-31 | $68.00K | -41.38% |
| 2018-12-31 | $116.00K | -53.96% |
| 2017-12-31 | $251.97K | -83.83% |
| 2016-12-31 | $1.56M | 486.76% |
| 2015-12-31 | $265.54K | -72.55% |
| 2014-12-31 | $967.50K | 423.15% |
| 2013-12-31 | $184.94K | 149.40% |
| 2012-12-31 | $74.15K | -94.55% |
| 2011-12-31 | $1.36M | - |
Nanobiotix generated $30.06M in revenue during NA 2023, up 529.36% compared to the previous quarter, and up 25912.07% compared to the same period a year ago.
Nanobiotix Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $30.06M | 82.64% |
| 2023-09-30 | $16.46M | 899.54% |
| 2023-06-30 | $1.65M | - |
| 2023-03-31 | $1.65M | -4.47% |
| 2022-12-31 | $1.72M | - |
| 2022-09-30 | $1.72M | 159.37% |
| 2022-06-30 | $664.50K | -6.34% |
| 2020-06-30 | $709.50K | - |
Nanobiotix generated $30.06M in revenue during Q4 2023, up 82.64% compared to the previous quarter, and up 1744.01% compared to the same period a year ago.
Nanobiotix Revenue Breakdown
Nanobiotix Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 21 | Dec 20 |
|---|---|---|---|
| Services | $29.75M | $5.00K | $50.00K |
| Other Sales | - | $5.00K | - |
Nanobiotix's latest annual revenue breakdown by segment (product or service), as of Dec 23: Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 21 |
|---|---|
| Other Sales | $5.00K |
| Services | $5.00K |
Nanobiotix's latest quarterly revenue breakdown by segment (product or service), as of Jun 21: Other Sales (50.00%), and Services (50.00%).
Nanobiotix Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 |
|---|---|---|
| Other Sales | $5.00K | - |
| Services | $5.00K | $50.00K |
Nanobiotix's latest annual revenue breakdown by geography, as of Dec 21: Other Sales (50.00%), and Services (50.00%).
Quarterly Revenue by Country
| Country | Jun 21 |
|---|---|
| Services | $5.00K |
| Other Sales | $5.00K |
Nanobiotix's latest quarterly revenue breakdown by geography, as of Jun 21: Services (50.00%), and Other Sales (50.00%).
Nanobiotix Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| WVE | Wave Life Sciences | $113.31M | $19.69M |
| NBTX | Nanobiotix | $30.06M | $30.06M |
| VECT | VectivBio | $27.34M | $676.00K |
| TCRX | TScan Therapeutics | $21.05M | - |
| CUE | Cue Biopharma | $5.49M | $3.34M |
| TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
| PALI | Palisade Bio | $250.00K | - |
| AVRO | AVROBIO | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| CYTO | Altamira Therapeutics | - | $52.73K |
| ZURA | Zura Bio | - | - |
| INAB | IN8bio | - | - |
| CGTX | Cognition Therapeutics | - | - |
| ANNX | Annexon | - | - |
| DRMA | Dermata Therapeutics | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
| ENVB | Enveric Biosciences | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |